Yuxintine

Developed for: major depressive disorder
Investigated by: Shanghai Innovative Research Center of Traditional Chinese Medicine · Shanghai Mental Health Center

today NCT02395263 · Ph 2

2015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT02395263	Mar 2015 → Mar 2016	major depressive disorder	Shanghai Mental Health Center	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Yuxintine	ClinicalTrials.gov intervention name — accepted as the source's own label NCT02395263 ↗
Route	Oral	“Yuxintine 200mg oral, once a day, 6 weeks” NCT02395263 ↗